Clinical Trials Directory

Trials / Completed

CompletedNCT03945344

Effect of Charcoal on Gastrointestinal Absorption of Tiotropium

Effect of Charcoal on Gastrointestinal Absorption of Tiotropium; A Randomised, Open, Single Centre, Single Dose, Crossover Study in Healthy Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Orion Corporation, Orion Pharma · Industry
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

The study will assess how efficiently activated charcoal will block absorption of tiotropium via the gastro intestinal track. Pharmacokinetics of tiotropium will be compared after orally administered tiotropium capsule with and without concomitant activated charcoal administration in healthy volunteers.

Conditions

Interventions

TypeNameDescription
DRUGTiotropiumOral capsule 20 μg
DRUGTiotropiumOral capsule 20 μg

Timeline

Start date
2019-05-27
Primary completion
2019-06-19
Completion
2019-06-19
First posted
2019-05-10
Last updated
2019-09-23

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT03945344. Inclusion in this directory is not an endorsement.